Loading...
DLB logo

Dolby Laboratories, Inc.NYSE:DLB Stock Report

Market Cap US$5.5b
Share Price
US$58.15
US$81
28.2% undervalued intrinsic discount
1Y-23.4%
7D-10.4%
Portfolio Value
View

Dolby Laboratories, Inc.

NYSE:DLB Stock Report

Market Cap: US$5.5b

Dolby Laboratories (DLB) Stock Overview

Engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. More details

DLB fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance1/6
Financial Health6/6
Dividends5/6

DLB Community Fair Values

Create Narrative

See what 28 others think this stock is worth. Follow their fair value or set your own to get alerts.

Software opportunity

Dolby Laboratories, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Dolby Laboratories
Historical stock prices
Current Share PriceUS$57.47
52 Week HighUS$78.28
52 Week LowUS$55.73
Beta0.86
1 Month Change-6.09%
3 Month Change-11.38%
1 Year Change-23.35%
3 Year Change-31.75%
5 Year Change-38.47%
Change since IPO136.50%

Recent News & Updates

Seeking Alpha May 03

Dolby: I Don't Mind Waiting In 2026

Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking Alpha

Recent updates

Seeking Alpha May 03

Dolby: I Don't Mind Waiting In 2026

Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking Alpha
Narrative Update May 01

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Narrative Update Apr 17

DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside

Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.
Narrative Update Apr 03

DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook

Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).
Narrative Update Mar 19

DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook

Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
Narrative Update Mar 05

DLB: Media Partnerships And Buybacks Will Support Measured Future Returns

Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
Narrative Update Feb 19

DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns

Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.
Narrative Update Feb 04

DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions

Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.
Analysis Article Feb 02

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...
Narrative Update Jan 21

DLB: Technology Adoption And Solid Execution Will Support Future Share Gains

Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.
Narrative Update Jan 06

DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption

Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.
Analysis Article Jan 05

Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...
Narrative Update Dec 21

DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption

Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.
Narrative Update Dec 07

DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds

Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.
Narrative Update Nov 23

DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds

Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.
Analysis Article Nov 11

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Sep 27

Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...
Narrative Update Sep 06

Expanding Auto And Device Ecosystems Will Define Immersive Entertainment

Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.
Analysis Article Jul 28

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...
Analysis Article May 27

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate

Key Insights Dolby Laboratories' estimated fair value is US$112 based on 2 Stage Free Cash Flow to Equity Dolby...
Seeking Alpha Feb 07

Dolby Laboratories Remains Fully Valued On Slow Growth

Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking Alpha

Shareholder Returns

DLBUS SoftwareUS Market
7D-10.4%3.1%2.1%
1Y-23.4%-6.3%30.6%

Return vs Industry: DLB underperformed the US Software industry which returned -7.9% over the past year.

Return vs Market: DLB underperformed the US Market which returned 31% over the past year.

Price Volatility

Is DLB's price volatile compared to industry and market?
DLB volatility
DLB Average Weekly Movement4.5%
Software Industry Average Movement9.7%
Market Average Movement7.2%
10% most volatile stocks in US Market16.1%
10% least volatile stocks in US Market3.2%

Stable Share Price: DLB has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: DLB's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19652,051Kevin Yeamanwww.dolby.com

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video.

Dolby Laboratories, Inc. Fundamentals Summary

How do Dolby Laboratories's earnings and revenue compare to its market cap?
DLB fundamental statistics
Market capUS$5.48b
Earnings (TTM)US$243.65m
Revenue (TTM)US$1.36b
22.3x
P/E Ratio
4.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DLB income statement (TTM)
RevenueUS$1.36b
Cost of RevenueUS$171.46m
Gross ProfitUS$1.19b
Other ExpensesUS$949.80m
EarningsUS$243.65m

Last Reported Earnings

Mar 27, 2026

Next Earnings Date

n/a

Earnings per share (EPS)2.58
Gross Margin87.44%
Net Profit Margin17.85%
Debt/Equity Ratio0%

How did DLB perform over the long term?

See historical performance and comparison

Dividends

2.5%
Current Dividend Yield
55%
Payout Ratio

Does DLB pay a reliable dividends?

See DLB dividend history and benchmarks
When do you need to buy DLB by to receive an upcoming dividend?
Dolby Laboratories dividend dates
Ex Dividend DateMay 12 2026
Dividend Pay DateMay 20 2026
Days until Ex dividend1 day
Days until Dividend pay date9 days

Does DLB pay a reliable dividends?

See DLB dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/07 16:54
End of Day Share Price 2026/05/07 00:00
Earnings2026/03/27
Annual Earnings2025/09/26

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dolby Laboratories, Inc. is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Patrick ShollBarrington Research Associates, Inc.
Eric WoldB. Riley Securities, Inc.